SCIENTIFIC HUB

Follow the evidence.

15.449 articles found

Source record

A randomized, double-blind, placebo-controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): rationale, design, and baseline characteristics.

Olanow CW, Hauser RA, Jankovic J, Langston W, Lang A, Poewe W, Tolosa E, Stocchi F, Melamed E, Eyal E, Rascol O.

Mov Disord · 2008-11-01

DOI: 10.1002/mds.22218PMID: 18932271

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record

Use of the new levodopa agent Stalevo (levodopa/carbidopa/entacapone) in the treatment of Parkinson's disease in out-patient clinical practice (the START-M open trial).

Boiko AN, Batysheva TT, Minaeva NG, Babina LA, Vdovichenko TV, Zhuravleva EY, Shikhkerimov RK, Malykhina EA, Khozova AA, Zaitsev KA, Kostenko EV.

Neurosci Behav Physiol · 2008-11-01

DOI: 10.1007/s11055-008-9085-3PMID: 18975095

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

Filters

Filters

Clear
Publication year
Research area
Author
Journal
Publication type
Source & language
Open accessAccess does not establish reuse rights.